The safety and efficacy of mesenchymal stem cell therapy in diabetic lower extremity vascular disease: a meta-analysis and systematic review
Authors:
- 1 March 2022
- journal article
- review article
- Published by Elsevier in Cytotherapy
- Vol. 24 (3) , 225-234
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell TherapyInternational Journal of Molecular Sciences, 2013
- Recent advances on the development of wound dressings for diabetic foot ulcer treatment—A reviewActa Biomaterialia, 2013
- Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb IschaemiaExperimental and Clinical Endocrinology & Diabetes, 2013
- Interventional Therapy in Diabetic Foot: Risk Factors, Clinical Events and Prognosis at One Year Follow-up (A Study of 103 Cases)Pakistan Journal of Biological Sciences, 2012
- Targeting Nonhealing Ulcers of Lower Extremity in Human Through Autologous Bone Marrow-Derived Mesenchymal Stem CellsRejuvenation Research, 2009
- Mechanisms involved in the therapeutic properties of mesenchymal stem cellsCytokine & Growth Factor Reviews, 2009
- In Search of the In Vivo Identity of Mesenchymal Stem CellsStem Cells, 2008
- Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemiaJournal of Medical Colleges of PLA, 2008
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueStem Cells, 2006
- Vascular evaluation and arterial reconstruction of the diabetic footClinics in Podiatric Medicine and Surgery, 2003